A clinical trial to test whether study drug could decrease damage from oxidative stress and inflammation related to acute muscle injury induced by eccentric continuous exercise.
- Registration Number
- CTRI/2018/05/014174
- Lead Sponsor
- Plant Lipids P limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
1.Age: more than 20 years
2.Subjects will be healthy, moderately active (regular aerobic exercise for at least 4 hours per week), non-smoking volunteers with no known musculoskeletal pathology.
3.Subjects should have a maximal oxygen consumption (VO2max) of at least 35 ml/kg, as assessed by the maximal treadmill exercise test.
4.Subjects willing to sign an informed consent and adhere to all protocol requirements.
1.Treatment with anti-inflammatory/analgesic/antioxidant drugs in the previous month,
2.Abnormal liver or renal function tests, laboratory findings suggestive of an active inflammatory or infectious process and presence of any known disease.
3.Pregnancy or breast feeding
4.Current alcoholism or drug abuse
5.Allergies to one of the component substances in the trial
6.medication (active medication)
7.Participation in another clinical trial less than 3 months previously.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method